Browsing Tag: abatacept biosimilar

Key Highlights:  Implications:   Dr. Reddy’s has secured CDSCO approval for its abatacept biosimilar (250 mg IV) for adults with moderate‑to‑severe active rheumatoid arthritis and activ...